Genmab A/S (GMAB)
NASDAQ: GMAB
· Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT
Genmab A/S Cash Flow Statement
Financials in DKK. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 7.22B | 8.3B | 5.09B | 6.08B | 6.39B | 5.35B | 5.37B | 5.94B | 6.71B | 7.04B | 7.34B | 5.24B | 3.17B | 3.98B | 3.57B | 3.07B | 6.97B |
Depreciation & Amortization | 416M | 422M | 481M | 391M | 241M | 240M | 411M | 411M | 404M | 398M | 317M | 309M | 308M | 304M | 281M | 277M | 270M |
Stock-Based Compensation | 578M | 721M | 688M | 664M | 639M | 586M | 546M | 502M | 464M | 439M | 408M | 376M | 339M | 310M | 279M | 244M | 216M |
Other Working Capital | -940M | -475M | -317M | -249M | -1.06B | 1.36B | 1.94B | 1.8B | 2.79B | 283M | 302M | -74M | -166M | n/a | -2.24B | 2.46B | -1.32B |
Other Non-Cash Items | -270M | -428M | 1.63B | 564M | 324M | 667M | 1B | 504M | -722M | -1.19B | -3.12B | -2.16B | -605M | -985M | -1.12B | -700M | -941M |
Deferred Income Tax | n/a | n/a | -327M | -511M | -690M | -826M | -957M | -913M | -868M | -732M | -274M | -134M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.39B | -1.04B | -636M | -249M | -1.06B | 1.36B | -272M | -410M | 573M | -1.93B | -468M | -844M | -936M | -770M | -1.26B | 3.45B | -615M |
Operating Cash Flow | 6.54B | 7.77B | 6.73B | 6.74B | 5.66B | 7.38B | 6.11B | 6.04B | 6.56B | 3.91B | 3.75B | 2.23B | 1.63B | 2.23B | 1.19B | 5.82B | 5.43B |
Capital Expenditures | -199M | -197M | -170M | -220M | -300M | -376M | -419M | -403M | -364M | -317M | -275M | -270M | -281M | -252M | -242M | -211M | -277M |
Cash Acquisitions | -12.25B | -12.25B | -11.87B | -12.98B | -721M | -812M | -1.16B | 1.25B | 1.74B | 1.83B | 1.81B | 508M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.35B | -8.64B | -9.67B | -9.05B | -12.59B | -10.91B | -10.83B | -12.74B | -10.57B | -9.7B | -9.26B | -12.2B | -13.94B | -15.62B | -17.72B | -16.91B | -10.28B |
Sales Maturities Of Investments | 8.4B | 11.28B | 11.66B | 11.95B | 10.18B | 10B | 10.27B | 9.78B | 8.83B | 7.25B | 6.61B | 9.3B | 13.17B | 14.91B | 16.6B | 14.81B | 7.62B |
Other Investing Acitivies | -135M | -1.53B | -1.8B | -761M | -692M | 812M | 1.16B | -1.25B | -1.74B | -2.44B | -2.66B | -2.9B | -768M | -709M | -1.13B | -2.1B | -2.66B |
Investing Cash Flow | -8.51B | -9.91B | -10.43B | -9.65B | -2.71B | -1.28B | -976M | -3.37B | -2.11B | -2.76B | -2.93B | -3.17B | -1.05B | -961M | -1.37B | -2.31B | -2.94B |
Debt Repayment | -38M | -60M | -85M | -68M | -78M | -75M | -76M | -93M | -78M | -73M | -55M | -59M | -62M | -58M | -64M | -56M | -48M |
Common Stock Repurchased | -3.35B | -3.9B | -3.89B | -3.6B | -576M | -574M | -579M | -1.27B | -1.46B | -982M | -980M | -293M | -329M | -456M | -453M | -444M | -201M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 20M | 5M | -3M | -18M | 68M | 47M | 201M | 253M | 193M | 192M | 59M | 43M | 56M | 86M | 109M | 85M | 74M |
Financial Cash Flow | -3.34B | -3.92B | -3.94B | -3.65B | -590M | -606M | -453M | -1.11B | -1.34B | -789M | -904M | -238M | -264M | -420M | -403M | -408M | -164M |
Net Cash Flow | -4.57B | -5.01B | -7.93B | -6.54B | 2.38B | 4.97B | 3.9B | 1.06B | 3.22B | 936M | 1.65B | 339M | 1.18B | 1.7B | -163M | 2.87B | 2.35B |
Free Cash Flow | 6.35B | 7.57B | 6.56B | 6.51B | 5.36B | 7B | 5.69B | 5.63B | 6.2B | 3.6B | 3.48B | 1.96B | 1.35B | 1.98B | 947M | 5.61B | 5.15B |